What is a stock summary page? Click here for an overview.
Business Description
Lixte Biotechnology Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US5393191037
Description
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.72 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 31.7 | |||||
| 3-Year EPS without NRI Growth Rate | 31.8 | |||||
| 3-Year FCF Growth Rate | 23 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.38 | |||||
| 9-Day RSI | 39.58 | |||||
| 14-Day RSI | 39.47 | |||||
| 3-1 Month Momentum % | -48.07 | |||||
| 6-1 Month Momentum % | -32.78 | |||||
| 12-1 Month Momentum % | -60.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | |||||
| Quick Ratio | 3.6 | |||||
| Cash Ratio | 3.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -155.09 | |||||
| ROA % | -133.73 | |||||
| ROIC % | -1538.33 | |||||
| 3-Year ROIIC % | 1991.77 | |||||
| ROCE % | -154.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.58 | |||||
| EV-to-EBITDA | -1.58 | |||||
| EV-to-FCF | -1.78 | |||||
| Price-to-Net-Cash | 3.66 | |||||
| Earnings Yield (Greenblatt) % | -63.29 | |||||
| FCF Yield % | -100.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:LIXT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Lixte Biotechnology Holdings Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.59 | ||
| Beta | 1.35 | ||
| 3-Year Sharpe Ratio | -0.6 | ||
| 3-Year Sortino Ratio | -0.8 | ||
| Volatility % | 62.1 | ||
| 14-Day RSI | 39.47 | ||
| 14-Day ATR ($) | 0.117323 | ||
| 20-Day SMA ($) | 1.223335 | ||
| 12-1 Month Momentum % | -60.97 | ||
| 52-Week Range ($) | 1.02 - 3.74 | ||
| Shares Outstanding (Mil) | 2.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Lixte Biotechnology Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Lixte Biotechnology Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Lixte Biotechnology Holdings Inc Frequently Asked Questions
What is Lixte Biotechnology Holdings Inc(LIXT)'s stock price today?
The current price of LIXT is $1.17. The 52 week high of LIXT is $3.74 and 52 week low is $1.02.
When is next earnings date of Lixte Biotechnology Holdings Inc(LIXT)?
The next earnings date of Lixte Biotechnology Holdings Inc(LIXT) is 2025-05-09 Est..
Does Lixte Biotechnology Holdings Inc(LIXT) pay dividends? If so, how much?
Lixte Biotechnology Holdings Inc(LIXT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers